Content is king, but in our industry, that king must always be compliant. This is usually top of mind when writing and deploying market-facing materials, but how do you know they will stay current? How can you know whether the training and assets you produce continue to be engaging and actively used, which would assure you that your field team …
MSLs are under increasing pressure to provide complex scientific information to stakeholders. By Kristina BelyeaDirector of Content Marketing ACTO Over the past three years, there have been significant shifts and pivots in life sciences, including changes in how healthcare providers (HCPs)want to interact with pharmaceutical companies. This shift has made medical affairs and medical sciences liaisons (MSLs) increasingly crucial and …
Featuring: This episode features Rich Benedetto and Jeff Ainsworth. Rich is a former Sr. Executive Sales Representative at a global pharmaceutical company has over 35 years of experience in the pharmaceutical industry. Jeff is the VP of Global Sales and Business Development at ACTO. Jeff has nearly 15 years of experience as a sales leader and coach in the pharmaceutical …
The Covid-19 pandemic has impacted the world in every conceivable way. One of the most significant changes has been the transformation of the life sciences industry and the accelerated rate at which drugs and medical devices are being brought to market. Before the pandemic, the industry was already going through a major transformation with Value-Based Care, Obamacare, and the Sunshine …
Landmark deal supports ACTO’s vision of driving world-class educational outcomes across the care continuum TORONTO, Oct. 29, 2020 /PRNewswire/ – ACTO, the Omnichannel Education and Engagement platform for life sciences, today announced its acquisition of CoHealth, a mobile application that provides trusted resources for patients and caregivers. The deal is ACTO’s second strategic acquisition since securing $11.5 million this summer, and brings a new …
TORONTO, Sept. 10, 2020 /PRNewswire/ – ACTO, the leading omnichannel education and engagement platform for life sciences, today announced its acquisition of Scrimmage, a pioneering mobile learning provider. Following ACTO’s $11.5M Series A round, the acquisition establishes ACTO as a life sciences SaaS leader with an unparalleled portfolio of 100+ clients, including seven of the top 20 pharma companies and six of the top …
TORONTO, Aug. 27, 2020 /PRNewswire/ – ACTO, the omnichannel education and engagement platform for life sciences, today announced the closing of a $11.5 million Series A round led by Resolve Growth Partners, a Baltimore-based growth equity firm focused on software entrepreneurs. The round also includes strategic funding from new investor Salesforce Ventures, as well as follow-on investment from existing investor Panache Ventures. ACTO is a …
TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …
TORONTO, Nov. 25, 2019 /CNW/ – Two of ACTO’s use cases have been nominated as finalists in the eyeforpharma Awards, which focus on recognizing genuine, truly innovative and meaningful approaches to excellence in the pharmaceutical industry. AstraZeneca has been nominated in the ‘Most Promising MVP/Pilot’ category for its ACTO use case. ACTO has been nominated in the ‘Most Valuable Data & Insights …
TORONTO, Aug. 22, 2019 /CNW/ – ACTO was named the winner of a Gold Stevie® Award in the Cloud Platform category in The 16th Annual International Business Awards®. The International Business Awards are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small – are eligible to submit nominations. The 2019 IBAs received …